Stay updated on Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA new revision entry, v3.7.0, has been added to the study record history and the old entry, v3.6.6, has been removed, updating the history to reflect the latest revision.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous v3.6.5, indicating a newer version of the page history.SummaryDifference0.1%

- Check67 days agoChange DetectedThe history page now displays revision v3.6.5, replacing the previous v3.6.4, indicating a new system version for the page's metadata. This is a backend versioning update and does not alter trial data or user-facing content.SummaryDifference0.1%

- Check81 days agoChange DetectedFooter revision updated from v3.6.3 to v3.6.4, indicating a newer build of the study record history page. The visible content and data on the page remain unchanged.SummaryDifference0.1%

- Check103 days agoChange Detected- The page's Revision label updated from v3.6.2 to v3.6.3, indicating a software version update. - This change only affects the UI/version badge and does not alter study content or data.SummaryDifference0.1%

Stay in the know with updates to Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial page.